Investigation of oxidative stress in relapse and remission periods of patients with relapsing-Remitting multiple sclerosis

被引:2
作者
Oncel, Samet [1 ]
Ozturk, Musa [2 ]
Gozubatik-Celik, Rabia Gokcen [2 ]
Soysal, Aysun [2 ]
Baybas, Sevim [2 ]
机构
[1] Batman Dunya Hosp, Dept Neurol, Batman, Turkey
[2] Univ Hlth Sci, Dept Neurol, Bakirkoy Training & Res Hosp Psychiat & Neurol Di, Istanbul, Turkey
关键词
Pathogenesis; progression; relapsing-remitting-multiple sclerosis; total antioxidant level;
D O I
10.4103/nsn.nsn_142_20
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. The role of oxidative stress has gained importance in the pathogenesis of free radicals in cells such as protein, lipid, and nucleic acids by showing myelin loss and axonal degeneration. In this study, serum total oxidant level total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and paraoxonase (PON) in patients with relapsing-remitting-MS (RRMS) were examined. The hypothesis was that antioxidants might indicate the attack phase or the progression phase. Methods: Twenty-four patients with RRMS known to have undergone new attacks and 24 healthy controls whose demographic data were appropriate were included. PON and TAS/TOS measurements were performed once in the healthy group and twice in the serum samples of patients during relapse and remission periods. The Number Cruncher Statistical System 2007 and Power Analysis and Sample Size 2008 Statistical Software (Utah, USA) program was used for statistical analysis. Results: TAS, TOS, and PON levels were similar in the patient and control groups during the attack. In remission, only a positive, statistically significant relationship between the duration of the disease and TAS measurements was noted (r = 0.435; P = 0.034). No significant relationship was found between sociodemographic characteristics, illness duration, laboratory/imaging findings, and antioxidant parameters in blood. Conclusion: In this study, TOS, TAS, OSI, and PON serum levels had no role in determining attack and remission periods in RRMS. There were only significant differences between disease duration and TAS results during the remission period. Following TAS results may help in monitoring progression in patients with early MS.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 20 条
[1]   Evaluation of serum oxidant/antioxidant balance in multiple sclerosis [J].
Acar, Abdullah ;
Cevik, M. Ugur ;
Evliyaoglu, Osman ;
Uzar, Ertugrul ;
Tamam, Yusuf ;
Arikanoglu, Adalet ;
Yucel, Yavuz ;
Varol, Sefer ;
Onder, Hakan ;
Tasdemir, Nebahat .
ACTA NEUROLOGICA BELGICA, 2012, 112 (03) :275-280
[2]   Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis [J].
Besler, HT ;
Çomoglu, S .
NUTRITIONAL NEUROSCIENCE, 2003, 6 (03) :189-196
[3]  
ECKERSON HW, 1983, AM J HUM GENET, V35, P1126
[4]   A novel automated method to measure total antioxidant response against potent free radical reactions [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2004, 37 (02) :112-119
[5]   A new automated colorimetric method for measuring total oxidant status [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2005, 38 (12) :1103-1111
[6]   Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity [J].
Ferretti, G ;
Bacchetti, T ;
Principi, F ;
Di Ludovico, F ;
Viti, B ;
Angeleri, VA ;
Danni, M ;
Provinciali, L .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (06) :677-682
[7]   NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury [J].
Fischer, Marie T. ;
Sharma, Rakhi ;
Lim, Jamie L. ;
Haider, Lukas ;
Frischer, Josa M. ;
Drexhage, Joost ;
Mahad, Don ;
Bradl, Monika ;
van Horssen, Jack ;
Lassmann, Hans .
BRAIN, 2012, 135 :886-899
[8]   The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy [J].
Gilgun-Sherki, Y ;
Melamed, E ;
Offen, D .
JOURNAL OF NEUROLOGY, 2004, 251 (03) :261-268
[9]   Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? [J].
Gonsette, Re .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (01) :22-34
[10]  
Hadzovic-Dzuvo A, 2011, BOSNIAN J BASIC MED, V11, P33